Kythera, Intercept Dazzle with Dueling Initial Public Offerings
Intercept Pharmaceuticals Inc. and Kythera Biopharmaceuticals Inc. each priced initial public offerings (IPO) at the top of their ranges Thursday, and both companies' stock surged, selling several dollars above even that top price.
Intercept (NASDAQ:ICPT) gained 30 percent, or $4.40, to close at $19.40, and Kythera (NASDAQ:KYTH) gained 23.7 percent, or $3.79, to close at $19.79.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter